Human Polyclonal MKK3 Ab
- Known as:
- Human Polyclonal MKK3 Antibody
- Catalog number:
- a0513
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- ABclonal
- Gene target:
- Human Polyclonal MKK3
Ask about this productRelated genes to: Human Polyclonal MKK3 Ab
- Gene:
- MAP2K3 NIH gene
- Name:
- mitogen-activated protein kinase kinase 3
- Previous symbol:
- PRKMK3
- Synonyms:
- MEK3, MKK3, MAPKK3
- Chromosome:
- 17p11.2
- Locus Type:
- gene with protein product
- Date approved:
- 1997-11-11
- Date modifiied:
- 2016-10-05
Related products to: Human Polyclonal MKK3 Ab
Related articles to: Human Polyclonal MKK3 Ab
- Deoxynivalenol (DON), a widely prevalent mycotoxin in temperate climates, causes significant hepatic injury upon the consumption of contaminated cereals. However, the key targets and mechanisms underlying DON-induced inflammatory hepatic injury remain unclear, thus hindering the development of targeted therapeutics. - Source: PubMed
Publication date: 2026/06/06
Yang YaqinWu YueXu XiaoqingIhsan AwaisHan LiWang Xu - The perioperative period represents a critical window in cancer management, during which anesthetic choice may influence tumor biology. Sevoflurane, a volatile anesthetic widely used in neurosurgery, has been shown to modulate gene expression in glioblastoma (GBM). This study aimed to identify novel biomarkers in GBM and to investigate their functional roles and prognostic significance, thereby exploring the potential impact of this common perioperative agent on tumor behavior and patient outcomes. - Source: PubMed
Publication date: 2026/05/22
Tang RuiChen HuYan YaLei Xiaofeng - Pulmonary vascular remodeling (PVR) is primarily driven by the aberrant proliferation and migration of vascular cells, with pulmonary artery smooth muscle cells (PASMCs) playing a central role. High mobility group protein B1 (HMGB1), a damage-associated molecular pattern (DAMP) molecule, is released via apoptosis, necrosis, or inflammatory cell activation and contributes to the pathological progression of various cardiopulmonary diseases. However, the mechanism by which HMGB1 regulates PASMCs to participate in PVR remains to be elucidated. PASMCs were stimulated with recombinant HMGB1. Proliferation of PASMCs was detected using CCK-8 and EdU assays, and migration of PASMCs was assessed by cell scratch and Transwell experiments. RNA-Seq was performed to profile transcriptomic changes in HMGB1-treated PASMCs, followed by bioinformatic analysis to identify DEGs and associated signaling pathways. Validation of DEGs was conducted using qRT-PCR and Western blotting. Monocrotaline (MCT) constructs a rat pulmonary vascular remodeling model to verify protein expression levels. HMGB1 treatment upregulated MAP2K3 expression and activated p38 phosphorylation in PASMCs, driving cell proliferation and migration. Silencing MAP2K3 or administering the p38 inhibitor SB203580 reversed the HMGB1-induced cellular functional changes and downregulated the expression of inflammatory cytokines (IL-1β, IL-6, TNF-α). HMGB1 also upregulated the Bcl-2/Bax ratio, inducing apoptosis resistance, while the inhibitors restored apoptotic balance. In a rat model of MCT-induced pulmonary vascular remodeling, MAP2K3 expression and p38 phosphorylation levels were significantly elevated, accompanied by pathological changes such as vascular wall thickening and increased muscularization. In addition, intervention with the HMGB1 inhibitor glycyrrhizin or SB203580 blocked MAP2K3/p38 activation, alleviated pulmonary vascular remodeling, inhibited cell proliferation, and restored apoptotic balance. This study elucidates that HMGB1 may drive PASMC proliferation and migration via the MAP2K3/p38 signaling axis, thereby contributing to pulmonary vascular remodeling. These findings provide new ideas for the treatment of pulmonary vascular remodeling diseases. - Source: PubMed
Publication date: 2026/05/29
Wang Ya-MeiWang Wen-TingLiang Jia-YiXu Wen-JingLi Hao-YanGao Yu-TaoWang Huan-Liang - Maxim (DrT) is a well-known traditional medicinal and edible plant with hepatoprotective effects. In this study, crude polysaccharides of DrT (DrTPs) were obtained using the water extraction-ethanol precipitation method. Autoimmune hepatitis (AIH) models of both mice and ALM12 cells were produced by ConA. The serum liver function indexes (AST and ALT) were examined by ELISA, and liver tissue pathological changes were observed by HE staining. The hepatoprotective mechanism of DrTP80 was explored by RNA sequencing and verified by detecting the protein expressions using Western blot. As a result, DrTP80 could significantly reduce AST and ALT levels in the injured liver and ALM12 cells. DrTP80 also obviously improved the hepatopathological changes in liver tissue induced by ConA. Furthermore, RNA sequencing detected significant differences in gene expression, and the functions of differential genes were focused on TNF and IL-17 signaling pathways. Based on these two signaling pathways, 13 differentially expressed genes (Vcam1, Atf6b, Akt1, Irf1, Map2k3, Lcn2, Hsp90ab1, Anapc5, Traf4, Fosl1, Jun, Cxcl5, Nfκbia) among NC, CRC, and FP groups were screened and verified by Western blot. In conclusion, our results demonstrated that DrTP80 can alleviate immune liver damage induced by ConA, and its hepatoprotective mechanism may be related to regulating TNF and IL-17 signaling pathways. Our findings indicated that DrTP80 could be exploited as a healthy food supplement for the treatment of immune liver injury. - Source: PubMed
Publication date: 2026/03/24
Guo MinWei SaixueCheng BiaobiaoLi Xiaodong - The mechanisms underlying the predilection of atopic dermatitis for the antecubital and popliteal fossae remain unexplored. This preliminary exploratory study aimed to characterize the proteomic features of typical flexural atopic dermatitis lesions using proteomics integrated with animal model validation and to clarify the therapeutic mechanisms of Aida lotion. - Source: PubMed
Publication date: 2026/03/31
Liu FangrongLi MinGong JianYe JunhongQiu ShanyuXu KeLiu QiaoWu Weiwei